Company profile: Radius Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of drug therapies for osteoporosis and women's health, including TYMLOS (abaloparatide) for treatment of osteoporosis in postmenopausal women and men at high risk for fracture. Offers Radius Assist to provide TYMLOS at no cost to eligible patients, and supports investigator-initiated study grants and medical education grants to enhance understanding and patient care.
Products and services
- TYMLOS (abaloparatide): An injection-based drug therapy treating osteoporosis in postmenopausal women and men at high fracture risk, with the goal of reducing future fractures and improving quality of life
- Investigator Initiated Study Grants: Clinical/preclinical funding that supports investigator-proposed studies to enhance understanding of Radius products or explore new research ideas
- Radius Assist: An eligibility-based patient assistance program that delivers TYMLOS injection therapy at no cost to eligible patients who cannot afford treatment
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Radius Pharmaceuticals
Tecres
HQ: Italy
Website
- Description: Provider of bone cement and biomaterials, specialized in acrylic resins. Since 1981, works closely with surgeons to develop innovative, safe and effective products, driven by technology and research to improve quality of life.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tecres company profile →
Vertos Medical
HQ: United States
Website
- Description: Provider of medical devices and minimally invasive treatments for lumbar spinal stenosis (LSS), including percutaneous lumbar decompression solutions such as the mild Procedure, designed to relieve back pain and improve mobility by removing small pieces of bone and excess ligament tissue; develops and markets devices used to treat common spinal diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vertos Medical company profile →
Pivot Medical
HQ: United States
Website
- Description: Provider of novel technologies for minimally invasive orthopedic treatments, developing and marketing advancements for a rapidly growing segment of the orthopedic marketplace.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pivot Medical company profile →
Spineway
HQ: France
Website
- Description: Provider of design, production and international sales of spinal implants and instruments to surgically treat severe spinal pathologies, including MONT BLANC posterior spinal implant systems (standard and MIS), TWIN PEAKS TLIF curved and oblique lumbar interbody fusion systems, disc prostheses for cervical and lumbar regions, and hydroxyapatite bone graft substitute gel.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spineway company profile →
Engage Surgical
HQ: United States
Website
- Description: Provider of the only cementless unicompartmental (partial) knee system commercially available in the US.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Engage Surgical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Radius Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Radius Pharmaceuticals
2.2 - Growth funds investing in similar companies to Radius Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Radius Pharmaceuticals
4.2 - Public trading comparable groups for Radius Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →